Eli Lilly’s deals add late- and early-stage vaccine assets: a potentially better-tolerated shingles candidate, bacterial ...

The STAND Act (HR 6835) expands spinal cord injury care via annual preventive evaluations and improved access to prosthetics and assistive mobility devices for eligible veterans. The Travel Assistance ...

Key Takeaways. Caregiver fear and availability meaningfully influence patient willingness to pursue CAR T and other immune effector therapies, contributing to persistently low uti ...

Vaccine news shaping the 2026-2027 immunization season includes major acquisitions, a key FDA panel vote, and new data on influenza vaccine effectiveness. 259 Prospect Plains Rd, Bldg H Cranbury, NJ ...

Orca-T integrates HSPCs for reconstitution, highly purified Tregs for GVHD suppression, and Tcons to accelerate immune recovery and preserve graft-versus-leukemia activity via a matched-donor, patient ...

This study evaluated whether adherence to a hypertension quality measure correlates with actual blood pressure control. Findings reveal misalignment between adherence metrics and clinical outcomes.

Real-world data reveal racial disparities in cancer pain medication timing and strong opioid prescribing, with gaps most pronounced in breast and prostate cancer. Patients from racially and ethnically ...

NCCN now recommends pemivibart pre-exposure prophylaxis for patients with B-cell lymphomas and other profoundly immunocompromised populations, aligning with IDSA guidance for ages ≥12 years. Humoral ...

Increasing frontline covalent BTK inhibitor use and emerging BTKi+BCL2i+anti-CD20 triplets constrain the R/R BTK-naïve ...

CDC ended the federal response June 24, 2026, after risk diminished, releasing >100 deployed staff from the peak incident ...

Legislation delays mandatory digital-only quality reporting for Shared Savings Program ACOs, addressing gaps in EHR/IT infrastructure that disproportionately affect smaller, rural, and independent ...

AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...